Since 2006, an increasing number of studies have demonstrated the usefulness of urinary NGAL (uNGAL) in the diagnosis and monitoring of LN, but there is a wide range of variability in uNGAL's diagnostic performance. The gene discussed is LCN2; the disease is lobular neoplasia.